Amneal Pharmaceuticals of New York, LLC recalls Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceu
Recalled February 28, 2024 · FDA recall D-0327-2024 · Amneal Pharmaceuticals of New York
Hazard
Failed Impurities/Degradation Specifications: Out-of-specification test results. · FDA Class II
Units
46,037 Bottles
Sold at
Nationwide in the USA
Description
Failed Impurities/Degradation Specifications: Out-of-specification test results.
Product
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6
Manufacturer(s)
Amneal Pharmaceuticals of New York, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →